Clinical Trial Update: A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1) [Phase 3]

View source ↗

Summary

Phase 3 patient-handling study of a mometasone furoate/formoterol fumarate MDI with an integrated dose counter in adolescents and adults with asthma or COPD; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Mometasone Furoate/Formoterol Fumarate MDI with Integrated Dose Counter (mometasone furoate/formoterol fumarate)

Snippet

Sponsor: Organon and Co | Conditions: Asthma, COPD | Phase 3 | Status: COMPLETED | Results posted: 2011-04-12